167 related articles for article (PubMed ID: 24081388)
1. Radium - 223 (Xofigo) for prostate cancer.
Med Lett Drugs Ther; 2013 Sep; 55(1426):79-80. PubMed ID: 24081388
[No Abstract] [Full Text] [Related]
2. Prostate cancer - Therapy with radium-223.
Brito AE; Amorim BJ; Martello M; Bernardo WM; Etchebehere E;
Rev Assoc Med Bras (1992); 2017 Dec; 63(12):1019-1023. PubMed ID: 29489974
[No Abstract] [Full Text] [Related]
3. Radium-223 chloride: Extending life in prostate cancer patients by treating bone metastases.
Wissing MD; van Leeuwen FW; van der Pluijm G; Gelderblom H
Clin Cancer Res; 2013 Nov; 19(21):5822-7. PubMed ID: 24052017
[TBL] [Abstract][Full Text] [Related]
4. [Good risk/benefit profile of treatment with confirmed alpha emitter].
Rev Med Suisse; 2015 Nov; 11(493):2082. PubMed ID: 26685653
[No Abstract] [Full Text] [Related]
5. Radium-223 dichloride for metastatic castration-resistant prostate cancer: the urologist's perspective.
Shore ND
Urology; 2015 Apr; 85(4):717-24. PubMed ID: 25681834
[TBL] [Abstract][Full Text] [Related]
6. Radium Ra 223 dichloride in castration-resistant prostate cancer.
Joung JY; Ha YS; Kim IY
Drugs Today (Barc); 2013 Aug; 49(8):483-90. PubMed ID: 23977665
[TBL] [Abstract][Full Text] [Related]
7. [Alpha emitter radium-223 dichloride: new therapy in castration-resistant prostate cancer with symptomatic bone metastases].
Heinzer H; König F; Klutmann S
Urologe A; 2014 Apr; 53(4):519-23. PubMed ID: 24604017
[TBL] [Abstract][Full Text] [Related]
8. Management of bone metastases in prostate cancer: a review.
Bienz M; Saad F
Curr Opin Support Palliat Care; 2015 Sep; 9(3):261-7. PubMed ID: 26262831
[TBL] [Abstract][Full Text] [Related]
9. Radium-223 dichloride: a review of its use in patients with castration-resistant prostate cancer with symptomatic bone metastases.
Shirley M; McCormack PL
Drugs; 2014 Apr; 74(5):579-86. PubMed ID: 24610703
[TBL] [Abstract][Full Text] [Related]
10. Dosing, administration, and safety of radium-223: How I do it.
Dan TD; Doyle L; Raval AJ; Pridjian A; Gomella LG; Den RB
Can J Urol; 2016 Jun; 23(3):8301-5. PubMed ID: 27347625
[TBL] [Abstract][Full Text] [Related]
11. FDA approves radiopharmaceutical for metastatic prostate cancer.
Cancer Discov; 2013 Jul; 3(7):OF1. PubMed ID: 23847352
[TBL] [Abstract][Full Text] [Related]
12. [Cancer of the prostate. Xofigo in the hospitals].
Perspect Infirm; 2015; 12(5):61. PubMed ID: 26730434
[No Abstract] [Full Text] [Related]
13. Abiraterone and increased survival in metastatic prostate cancer.
Parker C; Sartor O
N Engl J Med; 2011 Aug; 365(8):767. PubMed ID: 21864180
[No Abstract] [Full Text] [Related]
14. Radium Ra 223 dichloride injection: U.S. Food and Drug Administration drug approval summary.
Kluetz PG; Pierce W; Maher VE; Zhang H; Tang S; Song P; Liu Q; Haber MT; Leutzinger EE; Al-Hakim A; Chen W; Palmby T; Alebachew E; Sridhara R; Ibrahim A; Justice R; Pazdur R
Clin Cancer Res; 2014 Jan; 20(1):9-14. PubMed ID: 24190979
[TBL] [Abstract][Full Text] [Related]
15. [Radium-223 treatment of bone metastases from castration-resistant prostate cancer].
Mortensen J; Højgaard L
Ugeskr Laeger; 2014 Jul; 176(30):1399-402. PubMed ID: 25292232
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer.
Matsubara N; Nagamori S; Wakumoto Y; Uemura H; Kimura G; Yokomizo A; Kikukawa H; Mizokami A; Kosaka T; Masumori N; Kawasaki Y; Yonese J; Nasu Y; Fukasawa S; Sugiyama T; Kinuya S; Hosono M; Yamaguchi I; Tsutsui H; Uemura H
Int J Clin Oncol; 2018 Feb; 23(1):173-180. PubMed ID: 28770408
[TBL] [Abstract][Full Text] [Related]
17. Practical guide to the use of radium 223 dichloride.
Den RB; Doyle LA; Knudsen KE
Can J Urol; 2014 Apr; 21(2 Supp 1):70-6. PubMed ID: 24775727
[TBL] [Abstract][Full Text] [Related]
18. Treatment landscape of metastatic prostate cancer: the role of radium-223.
Dermine A; Machiels JP
Acta Clin Belg; 2017 Feb; 72(1):19-23. PubMed ID: 27377415
[TBL] [Abstract][Full Text] [Related]
19. [Bone-targeted treatment in prostate cancer].
Géczi L; Sinkovics I
Magy Onkol; 2014 Sep; 58(3):199-203. PubMed ID: 25260084
[TBL] [Abstract][Full Text] [Related]
20. New treatment option: 223Ra chloride, the first approved unsealed α-emitting radiopharmaceutical.
Colletti PM
Clin Nucl Med; 2013 Sep; 38(9):724-5. PubMed ID: 23867617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]